Tinnitus Liquid
NDC Package 55714-4857-1
Package Information
Tinnitus (aconitum nap., baryta carb., baryta mur., capsicum, causticum, chenopodium anthelminticum, chininum sulphuricum, cinchona, glonoinum, graphites, hydrastis, kali bic., kali mur., lycopodium, phosphorus, pulsatilla, salicylicum ac., tabacum, thiosinaminum, viola odorata) liquids is formulated for associated symptoms such as ringing, buzzing, echoing, pressure, pain, throbbing and sensitivity to noise. This formulation utilizes a liquid delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-4857.
Identification & Billing
Clinical Specifications
- ACONITUM NAPELLUS 20 [hp_X]/mL
- ALLYLTHIOUREA 20 [hp_X]/mL
- ANEMONE PULSATILLA 20 [hp_X]/mL
- BARIUM CARBONATE 20 [hp_X]/mL
- BARIUM CHLORIDE DIHYDRATE 20 [hp_X]/mL
- CAPSICUM 20 [hp_X]/mL
- CAUSTICUM 20 [hp_X]/mL
- CINCHONA OFFICINALIS BARK 20 [hp_X]/mL
- DYSPHANIA AMBROSIOIDES 20 [hp_X]/mL
- GOLDENSEAL 20 [hp_X]/mL
- GRAPHITE 20 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 20 [hp_X]/mL
- NITROGLYCERIN 20 [hp_X]/mL
- PHOSPHORUS 20 [hp_X]/mL
- POTASSIUM CHLORIDE 20 [hp_X]/mL
- POTASSIUM DICHROMATE 20 [hp_X]/mL
- QUININE SULFATE 20 [hp_X]/mL
- SALICYLIC ACID 20 [hp_X]/mL
- TOBACCO LEAF 20 [hp_X]/mL
- VIOLA ODORATA 20 [hp_X]/mL
- Allergens - [CS]
- Allergens - [CS]
- Antimalarial - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Nitrate Vasodilator - [EPC] (Established Pharmacologic Class)
- Nitrates - [CS]
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
- Vasodilation - [PE] (Physiologic Effect)
- Vegetable Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-4857 - Tinnitus
- 55714-4857-1 - 30 mL in 1 BOTTLE, GLASS
- 55714-4857 - Tinnitus
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-4857-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of Tinnitus, a human over the counter drug labeled by Newton Laboratories, Inc.. This liquid is formulated for oral use and contains aconitum napellus; allylthiourea; anemone pulsatilla; barium carbonate; barium chloride dihydrate; capsicum; causticum; cinchona officinalis bark; dysphania ambrosioides; goldenseal; graphite; lycopodium clavatum spore; nitroglycerin; phosphorus; potassium chloride; potassium dichromate; quinine sulfate; salicylic acid; tobacco leaf; viola odorata as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on January 31, 2024. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714485701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.